202 In the index

HCG HCG

An FDA-approved fertility hormone for women, also used off-label after steroid use to help the body restart its own testosterone production. Its fertility use is well proven, and its off-label use for restarting natural hormone production is supported by how hormones work in the body and by clinical experience, even without formal approval for that purpose.

Also known as Pregnyl, Ovitrelle

Effects Hormonal

Routes Injectable Subcutaneous

Legal status Prescription drug

WADA Banned at all times

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 250-500 IU, 2-3 times weekly (off-label fertility-preserving use during TRT)

Reported range 250 IU every other day to 1000+ IU 2-3 times weekly, or higher short courses for fertility treatment

Route Subcutaneous or intramuscular injection

Frequency 2-3 times weekly (TRT support) or per fertility-specialist protocol

Duration Ongoing, alongside TRT (off-label use), or short courses (fertility treatment)

FDA-approved for fertility indications and hypogonadism; widely used off-label alongside testosterone therapy and by anabolic steroid users to maintain testicular size/function.

Where this comes from FDA prescribing information; off-label user-reported dosing

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.

Variants

Name	Abbr	Route	Notes
HCG (recombinant)	R-HCG	Subcutaneous	Recombinant HCG, e.g. Ovitrelle.